These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 20064603)

  • 1. Oxidative stress: Biomarkers and novel therapeutic pathways.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Exp Gerontol; 2010 Mar; 45(3):217-34. PubMed ID: 20064603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.
    Maiese K; Hou J; Chong ZZ; Shang YC
    ScientificWorldJournal; 2009 Oct; 9():1072-104. PubMed ID: 19802503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "O" class: crafting clinical care with FoxO transcription factors.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fork in the path: Developing therapeutic inroads with FoxO proteins.
    Maiese K; Hou J; Chong ZZ; Shang YC
    Oxid Med Cell Longev; 2009; 2(3):119-29. PubMed ID: 20592766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Regulation of Stem Cells and Differentiation: A Forkhead Box O Transcription Factor Perspective.
    Ludikhuize MC; Rodríguez Colman MJ
    Antioxid Redox Signal; 2021 May; 34(13):1004-1024. PubMed ID: 32847377
    [No Abstract]   [Full Text] [Related]  

  • 7. Should I stay or should I go: beta-catenin decides under stress.
    Hoogeboom D; Burgering BM
    Biochim Biophys Acta; 2009 Dec; 1796(2):63-74. PubMed ID: 19268509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clever cancer strategies with FoxO transcription factors.
    Maiese K; Chong ZZ; Shang YC; Hou J
    Cell Cycle; 2008 Dec; 7(24):3829-39. PubMed ID: 19066462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells.
    Mahmud DL; G-Amlak M; Deb DK; Platanias LC; Uddin S; Wickrema A
    Oncogene; 2002 Feb; 21(10):1556-62. PubMed ID: 11896584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.
    Maiese K; Chong ZZ; Shang YC
    Trends Mol Med; 2008 May; 14(5):219-27. PubMed ID: 18403263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new fork for clinical application: targeting forkhead transcription factors in cancer.
    Yang JY; Hung MC
    Clin Cancer Res; 2009 Feb; 15(3):752-7. PubMed ID: 19188143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.
    Maiese K
    Biomed Pharmacother; 2008; 62(4):218-32. PubMed ID: 18342481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
    Li F; Chong ZZ; Maiese K
    Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxO proteins: cunning concepts and considerations for the cardiovascular system.
    Maiese K; Chong ZZ; Shang YC; Hou J
    Clin Sci (Lond); 2009 Feb; 116(3):191-203. PubMed ID: 19118491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.
    Kashii Y; Uchida M; Kirito K; Tanaka M; Nishijima K; Toshima M; Ando T; Koizumi K; Endoh T; Sawada K; Momoi M; Miura Y; Ozawa K; Komatsu N
    Blood; 2000 Aug; 96(3):941-9. PubMed ID: 10910908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
    Kato S; Aoyama M; Kakita H; Hida H; Kato I; Ito T; Goto T; Hussein MH; Sawamoto K; Togari H; Asai K
    J Neurosci Res; 2011 Oct; 89(10):1566-74. PubMed ID: 21833990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
    Zhu H
    Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin and oxidative stress.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Curr Neurovasc Res; 2008 May; 5(2):125-42. PubMed ID: 18473829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.